<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD003809-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD003809-sec-0029"></div> <div class="table" id="CD003809-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Dentist/nurse‐applied fluoride: fluoride varnish compared to non‐fluoride (placebo) varnish for preventing early tooth decay (demineralised lesions) during fixed brace treatment</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="table-header separated">
<td align="left" valign="top" colspan="8" rowspan="1" class="table-header"> <p><b>Fluoride varnish compared to non‐fluoride (placebo) varnish for preventing early tooth decay (demineralised lesions) during fixed brace treatment</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="8" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> orthodontic patients (any age)<br><b>Setting:</b> orthodontic clinics in Sweden<br><b>Intervention:</b> fluoride varnish<br><b>Comparison:</b> non‐fluoride (placebo) varnish </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="3" rowspan="1" class="table-tint table-highlight"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Number of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Certainty of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>With non‐fluoride (placebo) varnish</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>With fluoride varnish</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Difference</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Number of participants with new DLs (new DLs)</p> <p>Assessed with: pre‐treatment and day of debond clinical intraoral photographs</p> <p>Follow‐up: 1.7 years</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>28.80%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>15%<br> (4 to 55.60) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13.80% fewer<br> (24.80 fewer to 26.80 more) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.52<br> (0.14 to 1.93) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>405<br> (2 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> LOW<sup>a,b</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The evidence that professional application of fluoride varnish (7700 or 10,000 ppm F) every 6 weeks to the teeth of patients wearing fixed orthodontic braces reduces the number of new DLs is equivocal </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Number of participants with more severe DLs (severity of DLs) (score 3 or 4 versus score 1 or 2) </p> <p>Follow‐up: 1.7 years</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>26%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>12%<br> (5.70 to 24.70) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14.10% fewer<br> (20.30 fewer to 1.30 fewer) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.46<br> (0.22 to 0.95) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>148<br> (1 RCT) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> LOW<sup>c,d</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The evidence suggests that when a dentist or nurse applies 7700 ppm F (ammonium fluoride) varnish every 6 weeks to a patient wearing a fixed orthodontic brace there may a reduction in the number of orthodontic patients with more severe DLs (score 3 or 4 versus score 1 or 2) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Number of participants with adverse effects (adverse effects)</p> <p>Follow‐up: 1.7 years</p> </td> <td align="" valign="top" colspan="4" rowspan="1" class="table-tint table-highlight"> <p>No evidence that the intervention had adverse effects</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>148<br> (1 RCT) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> LOW<sup>d,e</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Only 1 participant with an adverse event and not clear if this was directly related to the intervention </p> </td> </tr>
<tr class="separated">
<td align="left" valign="" colspan="8" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup><b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><br><b>CI:</b> confidence interval; <b>DLs:</b> demineralised lesions; <b>F:</b> fluoride; <b>ppm:</b> parts per million; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr>
<tr class="separated">
<td align="left" valign="" colspan="8" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="8"> <div class="table-footnote"> <p><sup>a</sup>Downgraded 1 level for indirectness (evidence from only 2 studies) (<a href="./references#CD003809-bbs2-0009">Stecksén‐Blicks 2007</a>; <a href="https://archie-cochrane-org.libaccess.lib.mcmaster.ca/sections/documents/view?version=z1910161233193262408841579991966%26format=REVMAN#STD-Sonesson-2019" target="_blank" class="external">Sonesson 2019</a>).<br><sup>b</sup>Downgraded 1 level for imprecision (insufficient number of participants with new DLs (guideline 300 to 400 events)).<br><sup>c</sup>Downgraded 1 level for imprecision (insufficient number of participants with the more severe DLs (guideline 300 to 400 events)).<br><sup>d</sup>Downgraded 1 level for indirectness (evidence from only 1 study) (<a href="./references#CD003809-bbs2-0008">Sonesson 2019</a>).<br><sup>e</sup>Downgraded 1 level for imprecision (insufficient number with adverse events and not clear if directly related to the intervention). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD003809-tbl-0002"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 2.</span> <span class="table-title">Dentist/nurse‐applied fluoride: 12,300 ppm F APF foam compared to 0 ppm F placebo foam for preventing early tooth decay (demineralised lesions) during fixed brace treatment</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="table-header separated">
<td align="left" valign="top" colspan="8" rowspan="1" class="table-header"> <p><b>12,300 ppm F APF foam compared to 0 ppm F placebo foam for preventing early tooth decay (demineralised lesions) during fixed brace treatment</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="8" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> orthodontic patients (any age)<br><b>Setting:</b> orthodontic department at dental hospital in China<br><b>Intervention:</b> 12,300 ppm F APF foam<br><b>Comparison:</b> 0 ppm F placebo foam </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="3" rowspan="1" class="table-tint table-highlight"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Certainty of the evidence<br> (GRADE)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Number of participants (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>With 0 ppm F placebo foam</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>With 12,300 ppm F APF foam</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Difference</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Number of participants with new DLs (new DLs)</p> <p>Assessed with: clinical assessment</p> <p>Follow‐up: mean 18 months</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>48.90%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>12.70%<br> (5.40 to 27.90) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>36.20% fewer<br> (43.60 fewer to 21 fewer) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.26<br> (0.11 to 0.57) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> LOW<sup>a,b</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>95<br> (1 RCT) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The evidence suggests that when foam, containing 12,300 ppm F, is applied by a dentist or a nurse, every 2 months, to the teeth of patients wearing fixed orthodontic appliances there might be a reduction in the number of patients who have at least 1 new DL </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Number of participants with more severe DLs (severity of DLs)</p> </td> <td align="" valign="top" colspan="7" rowspan="1" class="table-tint table-highlight"> <p>None of the trials reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Number of participants with adverse effects (adverse effects)</p> </td> <td align="" valign="top" colspan="7" rowspan="1" class="table-tint table-highlight"> <p>None of the trials reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="8" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup><b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><br><b>APF:</b> acidulated phosphate fluoride; <b>CI:</b> confidence interval; <b>DLs:</b> demineralised lesions; <b>F:</b> fluoride; <b>ppm:</b> parts per million; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="8" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="8"> <div class="table-footnote"> <p><sup>a</sup>Although effect size is large this was only for 1 study at unclear risk of bias and therefore downgraded 1 level (<a href="https://archie-cochrane-org.libaccess.lib.mcmaster.ca/sections/documents/view?version=z1910161233193262408841579991966%26format=REVMAN#STD-Jiang-2013" target="_blank" class="external">Jiang 2013</a>).<br><sup>b</sup>Downgraded 1 level for imprecision (insufficient number of participants with new DLs (guideline 300 to 400 events)). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD003809-tbl-0003"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 3.</span> <span class="table-title">Patient‐applied/used fluoride: 5000 ppm F toothpaste compared to 1450 ppm F toothpaste for preventing early tooth decay (demineralised lesions) during fixed brace treatment</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="table-header separated">
<td align="left" valign="top" colspan="8" rowspan="1" class="table-header"> <p><b>5000 ppm F toothpaste compared to 1450 ppm F toothpaste for preventing early tooth decay (demineralised lesions) during fixed brace treatment</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="8" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> orthodontic patients (any age)<br><b>Setting:</b> home use<br><b>Intervention:</b> 5000 ppm F toothpaste<br><b>Comparison:</b> 1450 ppm F toothpaste </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="3" rowspan="1" class="table-tint table-highlight"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Number of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Certainty of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>With 1450 ppm F toothpaste</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>With 5000 ppm F toothpaste</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Difference</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Number of participants with new DLs (new DLs)</p> <p>Assessed with: pre‐treatment and post‐treatment clinical intraoral photographs</p> <p>Follow‐up: 1.8 years</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>26.60%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>18.10%<br> (12.20 to 26.60) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.50% fewer<br> (14.30 fewer to 0 fewer) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.68<br> (0.46 to 1.00) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>380<br> (1 RCT) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> LOW<sup>a,b</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The evidence suggests that in patients wearing an orthodontic fixed brace use of a daily 5000 ppm F toothpaste compared with a daily 1450 ppm F toothpaste throughout treatment may lead to a reduction in the number of orthodontic patients with new DLs </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Number of participants with more severe DLs (severity of DLs)</p> </td> <td align="" valign="top" colspan="7" rowspan="1" class="table-tint table-highlight"> <p>None of the trials reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Number of participants with adverse effects (adverse effects)</p> </td> <td align="" valign="top" colspan="7" rowspan="1" class="table-tint table-highlight"> <p>None of the trials reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="8" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup><b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><br><b>CI:</b> confidence interval; <b>DLs:</b> demineralised lesions; <b>F:</b> fluoride; <b>ppm:</b> parts per million; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="8" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="8"> <div class="table-footnote"> <p><sup>a</sup>Downgraded 1 level due to single study at unclear risk of bias (<a href="https://archie-cochrane-org.libaccess.lib.mcmaster.ca/sections/documents/view?version=z1910161233193262408841579991966%26format=REVMAN#STD-Sonesson-2014" target="_blank" class="external">Sonesson 2014</a>).<br><sup>b</sup>Downgraded 1 level for imprecision (insufficient number of participants with new DLs (guideline 300 to 400 events)). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD003809-tbl-0004"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 4.</span> <span class="table-title">Patient‐applied/used fluoride: 250 ppm F mouthrinse (100 ppm F amine F/150 ppm NaF) compared to 0 ppm F placebo mouthrinse for preventing early tooth decay (demineralised lesions) during fixed brace treatment</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="table-header separated">
<td align="left" valign="top" colspan="8" rowspan="1" class="table-header"> <p><b>250 ppm F mouthrinse (100 ppm amine F/150 ppm NaF) compared to 0 ppm F placebo mouthrinse for preventing early tooth decay (demineralised lesions) during fixed brace treatment</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="8" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> orthodontic patients (any age)<br><b>Setting:</b> home use<br><b>Intervention:</b> 250 ppm F mouthrinse (100 ppm amine F/150 ppm NaF)<br><b>Comparison:</b> 0 ppm F placebo mouthrinse </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="3" rowspan="1" class="table-tint table-highlight"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Number of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Certainty of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>With 0 ppm F placebo mouthrinse</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>With 250 ppm F mouthrinse (100 ppm amine F/150 ppm NaF)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Difference</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Number of participants with new DLs (new DLs)</p> <p>Assessed with: QLF</p> <p>Follow‐up: 24.5 months</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>46.70%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>30.30%<br> (17.30 to 54.60) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16.30% fewer<br> (29.40 fewer to 7.90 more) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.65<br> (0.37 to 1.17) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>81<br> (1 RCT) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br> VERY LOW<sup>a,b</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The evidence is very uncertain about the effect of a daily 250 ppm F mouthrinse (100 ppm amine F/150 ppm NaF) compared with a daily 0 ppm F placebo mouthrinse on the number of patients wearing a fixed orthodontic brace with new DLs </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Number of participants with more severe DLs (severity of DLs)</p> </td> <td align="" valign="top" colspan="7" rowspan="1" class="table-tint table-highlight"> <p>None of the trials reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Number of participants with adverse effects (adverse effects)</p> </td> <td align="" valign="top" colspan="7" rowspan="1" class="table-tint table-highlight"> <p>None of the trials reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="8" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup><b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><br><b>CI:</b> confidence interval; <b>DLs:</b> demineralised lesions; <b>F:</b> fluoride; <b>NaF:</b> sodium fluoride; <b>ppm:</b> parts per million; <b>QLF:</b> quantitative light‐induced fluorescence; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="8" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="8"> <div class="table-footnote"> <p><sup>a</sup>Downgraded 2 levels: single study with a relatively small number of participants (81), at high risk of bias due to high attrition (33%) (<a href="https://archie-cochrane-org.libaccess.lib.mcmaster.ca/sections/documents/view?version=z1910161233193262408841579991966%26format=REVMAN#STD-van-der-Kaaij-2015" target="_blank" class="external">van der Kaaij 2015</a>).<br><sup>b</sup>Downgraded 1 level for imprecision (insufficient number of participants with new DLs (guidance 300 to 400 events)). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD003809-tbl-0005"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 5.</span> <span class="table-title">Fluoride‐releasing materials: resin‐modified glass ionomer cement compared to light‐cured composite resin for bonding orthodontic brackets for preventing early tooth decay (demineralised lesions) during fixed brace treatment</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="table-header separated">
<td align="left" valign="top" colspan="8" rowspan="1" class="table-header"> <p><b>Resin‐modified glass ionomer cement compared to light‐cured composite resin for bonding orthodontic brackets for preventing early tooth decay (demineralised lesions) during fixed brace treatment</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="8" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> orthodontic patients (any age)<br><b>Setting:</b> 2 dental teaching hospitals and 4 specialist orthodontic practices in UK and Republic of Ireland<br><b>Intervention:</b> resin‐modified glass ionomer cement<br><b>Comparison:</b> light‐cured composite resin </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="3" rowspan="1" class="table-tint table-highlight"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Number of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Certainty of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>With light‐cured composite resin</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>With resin‐modified glass ionomer cement</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Difference</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Number of participants with new DLs (new DLs)</p> <p>Assessed with: before and day of debond clinical intraoral photographs</p> <p>Follow‐up: 17.6 months</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>22.40%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>26.20%<br> (15.40 to 44.50) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.80% more<br> (6.90 fewer to 22.10 more) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 1.17<br> (0.69 to 1.99) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>173<br> (1 RCT) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> LOW<sup>a,b</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The evidence suggests that resin‐modified glass ionomer cement for bonding orthodontic brackets compared with light‐cured composite resin results in little to no difference in the number of orthodontic patients with new DLs </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Number of participants with more severe DLs of aesthetic concern (severity of DLs)</p> <p>Assessed with: pre‐treatment and day of debond clinical intraoral photographs</p> <p>Follow‐up: 17.6 months</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>8.00%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>9.40%<br> (3.60 to 24.80) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.40% more<br> (4.40 fewer to 16.90 more) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 1.18<br> (0.45 to 3.12) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>173<br> (1 RCT) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> LOW<sup>a,b</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The evidence suggests that using resin‐modified glass ionomer cement for bonding orthodontic brackets compared with light‐cured composite resin results in little to no difference in the number of orthodontic patients with more severe DLs of aesthetic concern </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Number of participants with adverse effects (adverse effects)</p> <p>Follow‐up: 17.6 months</p> </td> <td align="" valign="top" colspan="4" rowspan="1" class="table-tint table-highlight"> <p>No evidence that either intervention had adverse effects</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>173<br> (1 RCT) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> LOW<sup>a,b</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="8" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup><b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><br><b>CI:</b> confidence interval; <b>DLs:</b> demineralised lesions; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="8" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="8"> <div class="table-footnote"> <p><sup>a</sup>Downgraded 1 level: single study at unclear risk of bias (<a href="https://archie-cochrane-org.libaccess.lib.mcmaster.ca/sections/documents/view?version=z1910161233193262408841579991966%26format=REVMAN#STD-Benson-2019" target="_blank" class="external">Benson 2019</a>).<br><sup>b</sup>Downgraded 1 level for imprecision (insufficient number of participants with new DLs or more severe DLs (guidance 300 to 400 events)). </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
